Short tandem repeat profiling for the authentication of cancer stem-like cells.
cell line authentication
colorectal tumor
glioblastoma
human stem-like cell lines
short tandem repeat profiling
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
15 03 2021
15 03 2021
Historique:
received:
14
02
2020
revised:
09
10
2020
accepted:
12
10
2020
pubmed:
1
11
2020
medline:
20
7
2021
entrez:
31
10
2020
Statut:
ppublish
Résumé
Colorectal and glioblastoma cancer stem-like cells (CSCs) are essential for translational research. Cell line authentication by short tandem repeat (STR) profiling ensures reproducibility of results in oncology research. This technique enables to identify mislabeling or cross-contamination of cell lines. In our study, we provide a reference dataset for a panel of colorectal and glioblastoma CSCs that allows authentication. Each cell line was entered into the cell Line Integrated Molecular Authentication database 2.1 to be compared to the STR profiles of 4485 tumor cell lines. This article also provides clinical data of patients from whom CSCs arose and data on the parent tumor stage and mutations. STR profiles and information of our CSCs are also available in the Cellosaurus database (ExPASy) as identified by unique research resource identifier codes.
Identifiants
pubmed: 33128777
doi: 10.1002/ijc.33370
pmc: PMC7894552
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1489-1498Informations de copyright
© 2020 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of Union for International Cancer Control.
Références
Cancer Res. 1999 Feb 15;59(4):793-7
pubmed: 10029064
Regen Med. 2015;10(7):857-61
pubmed: 26506014
Genomics. 1991 Feb;9(2):264-9
pubmed: 2004775
Stem Cells Transl Med. 2016 Apr;5(4):511-23
pubmed: 26956206
Clin Cancer Res. 2008 Dec 15;14(24):8205-12
pubmed: 19088037
Nature. 2007 Jan 4;445(7123):111-5
pubmed: 17122771
Int J Cancer. 2013 Jun 1;132(11):2510-9
pubmed: 23136038
Nucleic Acids Res. 2009 Jan;37(Database issue):D925-32
pubmed: 18927105
Neuro Oncol. 2017 Aug 1;19(8):1097-1108
pubmed: 28204560
Cell Stem Cell. 2014 Apr 3;14(4):427-30
pubmed: 24702994
Mutat Res. 2004 Dec 21;568(2):275-82
pubmed: 15542114
In Vitro Cell Dev Biol Anim. 2017 Dec;53(10):880-887
pubmed: 29197028
Int J Cancer. 2020 Mar 1;146(5):1299-1306
pubmed: 31444973
Mol Oncol. 2017 Sep;11(9):1115-1129
pubmed: 28248456
Curr Opin Pharmacol. 2010 Aug;10(4):380-4
pubmed: 20561817
Neuromuscul Disord. 2017 May;27(5):439-446
pubmed: 28284873
Clin Cancer Res. 2008 Aug 1;14(15):4859-68
pubmed: 18676759
Oncotarget. 2016 Jul 12;7(28):44113-44128
pubmed: 27286453
Int J Legal Med. 2002 Apr;116(2):117-20
pubmed: 12056519
J Biomol Tech. 2018 Jul;29(2):25-38
pubmed: 29805321
Int J Cancer. 2021 Mar 15;148(6):1489-1498
pubmed: 33128777
Asian J Surg. 2018 May;41(3):274-278
pubmed: 28190751
J Neurooncol. 2017 Sep;134(3):505-512
pubmed: 28233083
Nat Methods. 2015 Jun;12(6):493-7
pubmed: 26020501
Nat Commun. 2015 Apr 30;6:7002
pubmed: 25926053
Chem Res Toxicol. 2019 Sep 16;32(9):1733-1736
pubmed: 31203605
PLoS One. 2015 Feb 25;10(2):e0116218
pubmed: 25714623
Stem Cells Int. 2018 Feb 18;2018:3292704
pubmed: 29531533
Cancer Res. 2003 Jul 1;63(13):3750-4
pubmed: 12839970